XML 26 R14.htm IDEA: XBRL DOCUMENT v3.25.3
Stock Options
 9 Months Ended
Sep. 30, 2025
Stock Options [Abstract]  
STOCK OPTIONS

NOTE 8 – STOCK OPTIONS

 

A summary of the status of the Company’s outstanding stock options and changes is presented below:

 

Stock Options  Options   Weighted
Average
Exercise
Price		   Aggregate
Intrinsic
Value		 
Options outstanding December 31, 2023   156,899   $0.04   $1,656,270 
Granted   20,000   $0.10      
Exercised   (156,899)  $0.04      
Expired   
—
   $
—
      
Options outstanding December 31, 2024   20,000   $0.10   $39,400 
Granted   
—
    
 
      
Exercised   
—
    
 
      
Expired   
—
    
 
      
Options outstanding September 30, 2025   20,000   $0.10   $35,400 
Shares exercisable at September 30, 2025   20,000   $0.10   $35,400 

During the nine months ended September 30, 2025 and 2024 the Company recognized $101,625 and $372,624, respectively, in stock-based compensation related to the above-mentioned options. During the three months ended September 30, 2025 and 2024 the Company recognized $33,875 and $33,875, respectively, in stock-based compensation related to the above-mentioned options. As of September 30, 2025 there is $33,875 of unrecognized expense for the above-mentioned options is expected to extend for 1.01 years and the weighted average contractual term of the options outstanding and of the option exercisable were 8.27 years.